Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04071730 Completed - Clinical trials for Effects of Immulina on Natural Killer Cells

Effects of Immulina on Immune Measures

Start date: September 3, 2019
Phase: N/A
Study type: Interventional

This small, randomized, double blind, placebo controlled pilot study is aimed at determining the effects of oral Immulina dietary supplementation on specific immune biomarkers in the blood.

NCT ID: NCT04071509 Completed - Clinical trials for Complications in Diagnostic Percutaneous Lung Biopsy Procedures

Prevention of PNX and Haemorrhagic Complications in Diagnostic Percutaneous Lung Biopsy Using the MIPP-Kit Device

MIPP-PNX1
Start date: February 4, 2019
Phase: N/A
Study type: Interventional

The study will assess the safety and feasibility of a new medical device, MIPP-Kit, for the prevention of complications during diagnostic, CT guided ,percutaneous lung needle biopsy.

NCT ID: NCT04071496 Completed - Clinical trials for Chronic Idiopathic Thrombocytopenic Purpura

Diagnostic of Chronic Thrombocytopenia

DIATROC
Start date: November 25, 2009
Phase:
Study type: Observational

The objective of this study is to provide simple and relevant clinical and biological elements to distinguish a possible Congenital Thrombocytopenia from a Chronic Idiopathic Thrombocytopenic Purpura .

NCT ID: NCT04071171 Completed - Acute Kidney Injury Clinical Trials

Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation

Start date: August 1, 2020
Phase: Phase 2
Study type: Interventional

The primary objectives of the BiPhox-Trial are to demonstrate, that the use of Biphozyl® as a replacement fluid in adult critically ill acute kidney injury (AKI) patients, results in a lower rate of pH excursions and of bicarbonate (HCO3-) excursions compared to the use of Phoxilium® during the studied continuous veno-venous hemofiltration (CVVH) interval with regional citrate anticoagulation (RCA). The secondary objectives of the BiPhox-Trial are to evaluate the time to pH level normalization and the HCO3- substitution rates after initiation of CVVH treatment. Further, to demonstrate that the use of Biphozyl® as a replacement fluid in adult critically ill AKI patients, results in a more stable acid-base-status as well as improved respiratory situation due to lower intracorporeal HCO3- and carbon dioxide levels compared to the use of Phoxilium® during the studied CVVH interval with RCA.

NCT ID: NCT04070105 Completed - Amputation Clinical Trials

No Power Bionic Lower Extremity Prosthesis

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Typically people need separate prosthetic feet for running and walking. To bridge the gap, this study will test the Compliant Adaptive Energy Storage and Return (CAESAR) foot. This foot can change from a walk mode to a run mode with the push of a button. The investigators will test and improve this foot design mechanically, and then test this design on individuals with lower limb amputation in a lab setting. The goal of this project is to develop a passive prosthetic foot that can serve two purposes in someone's daily life: walking and running, to allow them to be more active.

NCT ID: NCT04070053 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning (TheraPPP) Pathway

TheraPPP
Start date: August 23, 2019
Phase: N/A
Study type: Interventional

Treatment of patients with Hypoxemic respiratory failure (HRF) and Acute Respiratory Distress Syndrome (ARDS) is complex. Therapies that have been shown to save the lives of patients with HRF and ARDS are available but they are not always provided. To reduce practice variation and improve adherence to evidence-informed therapies, the investigators developed the Treatment of Hypoxemic Respiratory Failure (HRF) and ARDS with Protection, Paralysis, and Proning (TheraPPP) Pathway. The purpose of this pilot study is to test the feasibility and acceptability of the TheraPPP Pathway. To assess feasibility, the investigators will test the ability to measure adherence to the pathway as well as patient and economic outcomes. To assess perceptions about the acceptability of the TheraPPP Pathway, the investigators will conduct a survey to clinicians who used the Pathway.

NCT ID: NCT04069962 Completed - Geriatrics Clinical Trials

Effectiveness of CGA on QoL in Older Patients With Cancer Receiving Systemic Therapy

G-oncoCOACH
Start date: October 30, 2019
Phase: N/A
Study type: Interventional

The G-oncoCOACH study aims to evaluate the effectiveness of the Comprehensive Geriatric Assessment (CGA) process coordinated by a geriatric team in combination with intensive patient coaching compared to the current standard of care, which is CGA coordinated by an oncology team.

NCT ID: NCT04069637 Completed - Clinical trials for Early-Onset Scoliosis Deformity of Spine

Serum and Urine Titanium Levels in Children With Early Onset Scoliosis Treated With Growth-Sparing Instrumentation

Start date: November 7, 2019
Phase:
Study type: Observational [Patient Registry]

The investigators are conducting research to compare serum and urine titanium levels in children with early onset scoliosis who are being treated with certain types of metal spinal rods. These rods include traditional growing rods (TGR), magnetically-controlled growing rods (MCGR), and Vertical Expandable Prosthetic Titanium Rib (VEPTR). Children with metal rods may have elevated serum and urine titanium levels. These levels may remain elevated over time. The investigators will collect serum titanium levels from children with metal rods and children without metal rods to see if there are differences in their titanium levels. The investigators will then collect a second serum titanium level from children with metal rods at least 6 months later to see if the participants titanium levels remain elevated over time. The investigators will also collect urine titanium levels from children with metal rods to see if titanium is excreted in the urine.

NCT ID: NCT04069520 Completed - Clinical trials for Anterior Cruciate Ligament Injuries

Neuroplastic Mechanisms Underlying Augmented Neuromuscular Training

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this proposal is to determine the neural mechanisms of augmented neuromuscular training (aNMT). Participants will complete a 6-week course of neuromuscular training with either aNMT biofeedback or sham biofeedback. An MRI will be performed before and after the training program.

NCT ID: NCT04069403 Completed - Health Behavior Clinical Trials

An Opioid Prescribing Nudge

OHS
Start date: September 10, 2019
Phase: N/A
Study type: Interventional

Analyze baseline concurrent opioid prescribing metrics at the individual prescriber level in the Duke Health System on the identified three main outcome measures. Test the impact of reports on opioid prescriber behaviors with the following primary measures: number of prescriptions with concurrent benzo within reporting period, number of prescriptions with concurrent muscle relaxants within reporting period, and number of encounters with naloxone prescriptions for patients with any opioid-related diagnosis within reporting period. Create a blueprint to implement the concurrent opioid prescribing nudge intervention in other settings.